Your browser doesn't support javascript.
loading
Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials.
Lee, Christine; Louie, Thomas; Bancke, Lindy; Guthmueller, Beth; Harvey, Adam; Feuerstadt, Paul; Khanna, Sahil; Orenstein, Robert; Dubberke, Erik R.
Afiliación
  • Lee C; Medical Microbiologist and Researcher, Island Health, Clinical Professor, Department of Pathology and Laboratory Medicine, The University of British Columbia Faculty of Medicine, Vancouver, BC V6T 1Z3, Canada.
  • Louie T; Island Medical Program University of British Columbia, University of Victoria, Victoria, BC, Canada.
  • Bancke L; University of Calgary and Foothills Medical Center, Calgary, AB, Canada.
  • Guthmueller B; Rebiotix Inc., a Ferring Company, Roseville, MN, USA.
  • Harvey A; Rebiotix Inc., a Ferring Company, Roseville, MN, USA.
  • Feuerstadt P; Rebiotix Inc., a Ferring Company, Roseville, MN, USA.
  • Khanna S; Yale School of Medicine, New Haven, CT, USA.
  • Orenstein R; Mayo Clinic, Rochester, MN, USA.
  • Dubberke ER; Mayo Clinic, Phoenix, AZ, USA.
Therap Adv Gastroenterol ; 16: 17562848231174277, 2023.
Article en En | MEDLINE | ID: mdl-37333464
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Therap Adv Gastroenterol Año: 2023 Tipo del documento: Article País de afiliación: Canadá